Scissor-like Enzymes: Mehdi Alikhani’s research into matrix metalloproteinases (MMPs) and their practical implications
Like little scissors for our tissue, matrix metalloproteinases, or MMPs, are enzymes in our bodies that work to repair damaged tissue and aid in healing wounds.
Mehdi Alikhani, a postdoctoral researcher at the University of Notre Dame in the Department of Chemistry and Biochemistry, focuses on these MMPs. In Mayland Chang and Shahriar Mobashery’s lab, he looks at the role of MMPs in spinal-cord injuries, finding these enzymes in cerebrospinal fluid (CSF)–a clear liquid that protects and surrounds the spinal cord and brain.
MMPs are normally inactive in our bodies, only becoming active when they are needed. In fact, there is a certain type of protein called a tissue inhibitor, which can block the active site of the MMPs to ensure this.
However, in certain patients, like those with diabetes, the active MMPs outnumber the tissue inhibitors, which leads to the enzymes creating more damage than good. The Chang lab was able to manufacture a synthetic inhibitor specifically for diabetic patients that allows for their wounds to be properly healed.
Alikhani aims to identify and quantify active MMPs in CSF from humans, dogs with natural spinal cord injuries, and other animal models. He uses custom-made resins specifically designed to capture active MMPs coupled with advanced proteomics and spectrometry tools.
The work Alikhani does has additional practical uses, as his lab also works to create MMP inhibitors that prevent certain diseases or metastasis in cancer patients. The direct application of his work is one of the things Alikhani loves most about what he does.
“We can synthesize any compound we want, and from that, create a new drug. It’s very exciting to work in a lab where findings can be directly used in clinics,” said Alikhani.
Alikhani appreciates that his lab includes both biochemists and chemists, which opens up the breadth of the research that is possible. Because of this, Alikhani said, “We are much closer to a functional research lab than a basic one.”
In his previous positions, Alikhani would often have to send samples to off-site labs that had the proper specialized equipment to synthesize his compounds. Yet, Alikhani was drawn to Notre Dame for its robust chemistry and proteomics research facilities, which allows for everything to be done in-house.
In his free time, Alikhani enjoys attending the guest lectures and scientific talks that the College of Science hosts, particularly the ones that pertain to his department. “These scientists come from all over to share their research, and it’s really helpful to hear about their new ideas and discoveries,” Alikhani said.
Alikhani also appreciates taking walks around the campus. “The University is more beautiful than I could've even expected,” he said.
Being able to work in a lab where research directly translates into real-world solutions has been fulfilling for Alikhani, and he is excited to see the continued impact of the growing understanding of MMPs.
Originally published by science.nd.edu on December 09, 2024.
atLatest Research
- Brain tumor growth patterns may help inform patient care managementAssistant Professor Meenal Datta (University of Notre Dame/Wes Evard) A team of researchers from the University of Notre Dame, Harvard Medical School/Massachusetts General Hospital, and Boston University has developed a technique for measuring a brain tumor’s mechanical force and a new model to estimate how much brain tissue a patient has lost.
- Biseach Symposium Strengthens Cancer Research Partnership Between Notre Dame and University of Galway…
- Notre Dame announces new research collaborations with Ukrainian Catholic UniversitySeven faculty teams of collaborators from the University of Notre Dame (South Bend, Indiana, USA) and Ukrainian Catholic University (Lviv, Ukraine) have received grants from Notre Dame Global and Notre Dame Research to pursue…
- From reaction to resolution: The future of allergy treatmentTwelve-year-old Lauren Eglite was thrilled to attend a Notre Dame football game with her father, Erik, in 2017, even though her acute peanut allergy demands constant vigilance. She was even more excited when the stadium’s brand-new video board aired an NBC Fighting…
- New Study Highlights Mother-Child Link for Anemia in The GambiaAnemia is a "silent epidemic." It affects nearly 2 billion people globally, yet many people ignore its symptoms. Typically caused by the consumption of iron-deficient foods, anemia develops gradually. Its symptoms—such as fatigue, weakness, and shortness of breath—are frequently dismissed or misattributed.
- Megan McDermott joins ND–IBM Tech Ethics Lab as new Notre Dame directorThe Notre Dame–IBM Technology Ethics Lab, a critical component of the Institute for Ethics and the Common Good (ECG) and the Notre…